Table of Contents
Introduction: A New Chapter in Obesity Management
Obesity is a serious health problem that affects millions of people across the world. It is more than just carrying extra weight. Obesity can increase the risk of many other health problems, such as type 2 diabetes, heart disease, high blood pressure, sleep apnea, liver disease, and even some types of cancer. It can also make everyday activities harder and reduce a person’s quality of life. For many people, losing weight and keeping it off is very difficult, even with a healthy diet and regular exercise. This is why doctors and scientists continue to search for better ways to help people manage obesity.
In recent years, new medicines have changed how doctors treat type 2 diabetes and weight problems. One of the most talked-about drugs is called tirzepatide. Tirzepatide is a weekly injection that was first approved by the U.S. Food and Drug Administration (FDA) to treat type 2 diabetes. However, it is also showing strong results in helping people lose weight—even those without diabetes. Because of this, tirzepatide is getting a lot of attention in the medical world and from people who are trying to manage their weight more effectively.
Tirzepatide is not just another diet drug or weight loss pill. It works in a new way that affects the body’s natural hormones. These hormones help control hunger, insulin levels, and how the body uses food for energy. By working with these natural systems, tirzepatide helps people eat less, feel full longer, and lose weight over time. Clinical trials have shown that people taking tirzepatide can lose a large amount of weight—more than many other medicines available today.
This medicine may be especially important because obesity is now being understood as a chronic condition—not just a result of poor choices or lack of willpower. Many doctors now treat obesity as a long-term disease, similar to high blood pressure or diabetes. That means it may require ongoing treatment, support, and tools—including medicines like tirzepatide—to help people manage it in the long run.
The approval of tirzepatide for type 2 diabetes and the results seen in people with obesity are leading many experts to believe that this drug could be a turning point in how obesity is treated. It offers a new option for people who have struggled to lose weight with diet and exercise alone. It also supports the idea that medication can play an important role in weight management, especially when combined with healthy lifestyle changes.
Understanding how tirzepatide works and why it helps people lose weight is important. It helps patients know what to expect, and it helps doctors make informed decisions about care. It also helps remove the stigma that surrounds obesity. Many people still believe that weight loss is only about willpower. But science shows that the body’s hormones, brain signals, and metabolism all play a role—and these things are not easy to control without help.
Because of how well tirzepatide works and how it targets these systems in the body, researchers are now studying it further. They want to know how it affects heart health, liver disease, and other weight-related problems. There is also hope that tirzepatide could be approved in the future as a direct treatment for obesity, not just diabetes.
This article explains how tirzepatide works, how it helps people lose weight, what the studies show, who it is for, and what makes it different from other medicines. It also looks at safety, side effects, cost, and the long-term impact this drug might have on the future of treating obesity. As obesity rates continue to rise across the globe, new tools like tirzepatide may offer real hope to those who need better options for long-term weight management.
What Is Tirzepatide and How Does It Work?
Tirzepatide is a new type of medicine that helps people lose weight and control blood sugar. It was first made to treat type 2 diabetes but is now also being studied and used for weight loss. Tirzepatide is different from many older weight loss drugs because it works in a special way inside the body.
Tirzepatide belongs to a group of drugs called incretin mimetics. These drugs copy the action of natural hormones in the body known as incretins. Incretins are chemicals that the gut releases after eating. They help control blood sugar and affect how full a person feels after a meal. Tirzepatide copies the action of two different incretin hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
Most older drugs in this class copy only one hormone, GLP-1. Tirzepatide is the first drug to copy both GLP-1 and GIP at the same time. This makes it the first dual GIP and GLP-1 receptor agonist. The word “agonist” means it activates or turns on a receptor in the body, much like how a key turns a lock.
The Role of GLP-1 and GIP Hormones
GLP-1 and GIP help manage blood sugar and appetite. They are released from the gut when food is eaten. These hormones have several important effects:
- They help the pancreas release more insulin when blood sugar is high. Insulin is a hormone that moves sugar from the blood into the cells, where it can be used for energy.
- They lower the amount of glucagon made by the liver. Glucagon is a hormone that raises blood sugar, so reducing it helps control high blood sugar.
- They slow down how fast the stomach empties food into the intestines. This helps a person feel full for longer and eat less.
- They act on the brain, especially parts that control hunger and eating behavior.
When tirzepatide copies the actions of both GLP-1 and GIP, it strengthens these effects. As a result, the body has better control over blood sugar and appetite. This is why tirzepatide works well for both treating type 2 diabetes and helping with weight loss.
How Tirzepatide Was Developed
Tirzepatide was developed by the pharmaceutical company Eli Lilly. It went through many studies to make sure it works and is safe. These studies showed that tirzepatide lowers blood sugar in people with type 2 diabetes better than many other diabetes medicines. Later, doctors and scientists also saw that patients using tirzepatide were losing a lot of weight. This led to more research to see if it could help people with obesity who do not have diabetes.
Because of its results, tirzepatide became a major step forward in treating obesity. It is already approved by the U.S. Food and Drug Administration (FDA) to treat type 2 diabetes. It is also being reviewed and used for weight loss, especially in people who are overweight or have obesity, even if they do not have diabetes.
What Makes Tirzepatide Unique
The main reason tirzepatide is different from other weight loss drugs is its dual action. Most drugs that help people lose weight focus only on GLP-1. While GLP-1 is very helpful, combining it with GIP seems to improve the body’s response even more. Studies show that when both hormones are activated, the effects are stronger than using GLP-1 alone.
Tirzepatide does not just lower blood sugar or help with weight in one way. It works in several parts of the body:
- In the pancreas, it helps insulin release and lowers glucagon.
- In the stomach, it slows digestion so people feel full longer.
- In the brain, it reduces hunger and helps people eat fewer calories.
This multi-target action is part of what makes tirzepatide so effective.
Tirzepatide is a new and advanced medicine that copies two natural gut hormones: GLP-1 and GIP. By doing this, it helps lower blood sugar, reduces hunger, slows digestion, and supports weight loss. It was first made for diabetes, but now it is also being used to help treat obesity. Its unique dual-action design gives it strong effects that make it stand out from older treatments.
How Does Tirzepatide Lead to Weight Loss?
Tirzepatide helps people lose weight by changing how the body controls hunger, digestion, and how it uses energy. It works in several ways to reduce body fat and make it easier to eat less. These effects come from how tirzepatide acts on two important hormones in the body: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These hormones are called incretins, and they are normally released by the gut after eating. They help manage blood sugar and also affect appetite and metabolism.
Tirzepatide is special because it activates both the GLP-1 and GIP receptors. Most weight loss medicines work on just one of these. By acting on both, tirzepatide has a stronger effect on reducing hunger and helping the body burn more fat. It does this through three main actions: controlling appetite in the brain, slowing down digestion, and changing how the body stores and uses fat.
Appetite Regulation in the Brain
One of the key ways tirzepatide reduces weight is by lowering appetite. After a person eats, the gut sends signals to the brain to let it know that food has been consumed. GLP-1 and GIP are part of these signals. Tirzepatide copies these hormones and sends stronger signals to the brain, especially to an area called the hypothalamus. This part of the brain helps control hunger and fullness.
When the hypothalamus receives more of these signals, it tells the body that it is full. This helps people eat less without feeling as hungry. Tirzepatide also affects brain chemicals linked to cravings and reward. These changes can make food less appealing, especially high-calorie or high-fat foods. As a result, people often feel satisfied with smaller meals and have fewer food cravings.
Slowing Down Digestion and Increasing Fullness
Tirzepatide also slows down how quickly food leaves the stomach. This is called delayed gastric emptying. When food stays in the stomach longer, it creates a feeling of fullness that lasts more time after eating. People may feel full sooner during a meal and remain full for longer afterward. This helps reduce how much food is eaten during the day.
Slower digestion also has another benefit. It leads to a more gradual rise in blood sugar after meals. This helps keep energy levels more stable and may prevent the sudden hunger that can follow blood sugar drops. The slower movement of food through the gut supports a steady and controlled eating pattern, which contributes to long-term weight loss.
Changes in How the Body Uses Fat
Tirzepatide affects metabolism—the way the body burns calories and stores fat. By acting on GIP and GLP-1 receptors, the drug changes the way fat is stored and broken down. It reduces how much fat is stored in fat cells and increases the breakdown of existing fat for energy. This is important for reducing overall body weight and improving body composition.
At the same time, tirzepatide helps lower insulin resistance, which is often seen in people with obesity. When insulin works better in the body, it helps shift energy use away from storing fat and toward burning it. This shift supports long-term weight loss and may also improve health conditions linked to obesity, such as high blood sugar and high cholesterol.
Effects on Food Preferences and Caloric Intake
Another way tirzepatide supports weight loss is by changing food preferences. Many people who use tirzepatide report eating less fatty or sugary foods, even without trying. This may be due to how the drug affects reward centers in the brain. With fewer cravings for unhealthy foods, it becomes easier to choose balanced meals with fewer calories.
By reducing hunger, helping people feel full longer, and lowering interest in high-calorie foods, tirzepatide helps cut total daily calorie intake. When people eat fewer calories than their body uses, weight loss occurs over time. Studies show that many people on tirzepatide reduce their calorie intake by several hundred calories per day, without being on a strict diet plan.
Tirzepatide leads to weight loss by working on multiple systems in the body. It reduces appetite by sending strong fullness signals to the brain, slows digestion to help people feel full longer, and shifts how the body uses energy to promote fat burning. It also lowers cravings for high-calorie foods, helping people naturally eat less. These combined effects explain why tirzepatide can lead to significant and lasting weight loss in many people.
How Effective Is Tirzepatide for Weight Loss?
Tirzepatide has shown strong results in helping people lose weight. It works better than many other medicines used before for obesity and type 2 diabetes. This section explains how well tirzepatide works, based on clinical studies. It also shows how much weight people usually lose when they take it and how that compares to other treatments like diet and exercise alone.
Results From Clinical Trials
Tirzepatide has been tested in several large clinical trials. These studies included people with and without type 2 diabetes. The most well-known trials are the SURPASS trials (for people with type 2 diabetes) and the SURMOUNT trials (for people without diabetes). In these studies, tirzepatide was compared to a placebo or other diabetes medicines.
In the SURMOUNT-1 trial, which focused on people who had obesity or were overweight but did not have diabetes, the results were striking. Participants who took tirzepatide lost between 15% and 22.5% of their body weight over 72 weeks, depending on the dose. Those who received the highest dose (15 mg) lost an average of 52 pounds (about 24 kg). In comparison, people in the placebo group lost only about 5% of their body weight, or roughly 6 to 7 pounds (around 3 kg).
In people with type 2 diabetes, the weight loss was slightly less but still significant. In the SURPASS-2 trial, people who took tirzepatide lost between 7.6 kg and 12.9 kg (about 17 to 28 pounds) depending on the dose. This was more than people who took semaglutide, another weight-loss drug.
Weight Loss Depends on the Dose
Tirzepatide comes in several dose options: 5 mg, 10 mg, and 15 mg, taken once a week. Higher doses usually lead to more weight loss. In clinical trials, people who took 15 mg lost the most weight. Those who took 10 mg also lost a large amount, while people taking 5 mg still had good results, but not as much. Doctors usually start with a low dose and increase it over time. This helps reduce side effects and allows the body to adjust.
The weight loss effects of tirzepatide are dose-dependent, meaning that the more of the medicine taken (up to the approved maximum), the stronger the effect on weight. However, higher doses may also cause more side effects. So the right dose for each person depends on their health and how they tolerate the medicine.
How Tirzepatide Compares to Lifestyle Changes
Standard weight-loss advice usually includes eating a healthy diet and increasing physical activity. While these changes are important, they can be hard to maintain over time. Many people lose some weight with diet and exercise, but often gain it back. On average, people lose about 5% to 10% of their body weight with lifestyle changes alone, and many do not keep it off long term.
Tirzepatide has helped many people lose more than 20% of their body weight, especially when combined with healthy habits. This is a much larger weight loss than what is typically seen with diet and exercise alone. It also brings other health benefits, like improved blood sugar, lower blood pressure, and better cholesterol levels.
Why These Results Matter
Losing 5% to 10% of body weight can improve health. But losing 15% to 20% or more may lower the risk of heart disease, stroke, and type 2 diabetes even further. This level of weight loss has usually only been possible through bariatric (weight loss) surgery in the past. Tirzepatide now offers a non-surgical option that comes close to the same results.
These strong effects are changing how doctors think about treating obesity. Tirzepatide is not just a tool to help manage blood sugar in diabetes. It is now seen as a powerful treatment for weight loss, especially for people who have struggled to lose weight using traditional methods.
The high level of weight loss and the consistency of the results across different studies show that tirzepatide is one of the most effective weight loss medicines available today. It is giving people a new option for long-term weight control that is supported by strong scientific evidence.
Who Can Take Tirzepatide for Weight Loss?
Tirzepatide is a medicine that was first made to help people with type 2 diabetes. It helps control blood sugar and also leads to weight loss. Because of this strong effect on weight, many doctors are now also using tirzepatide to help people lose weight, even if they do not have diabetes. However, it is important to understand who may benefit from this treatment and who should avoid it.
Approved Use for Diabetes
The U.S. Food and Drug Administration (FDA) approved tirzepatide under the brand name Mounjaro to treat type 2 diabetes. This approval means that the medicine can be used safely in adults who need help controlling their blood sugar. Many people who have type 2 diabetes also struggle with being overweight or obese. For these patients, tirzepatide can offer two benefits—better blood sugar control and weight loss.
Off-Label Use for Weight Loss
Even though tirzepatide is not yet officially approved for weight loss alone (as of early 2025), doctors may prescribe it “off-label” for people who are overweight or obese. This is allowed in medical practice when there is strong evidence from studies showing that a drug is helpful for a different purpose than its original approval.
Many doctors choose tirzepatide for patients who have tried other methods to lose weight—like diet and exercise—but have not had enough success. Before starting the medicine, doctors usually make sure the person has no medical problems that would make tirzepatide unsafe to use.
Body Weight and Health Requirements
People who are overweight or obese may be candidates for tirzepatide. Doctors often use the Body Mass Index (BMI) to help decide. BMI is a number calculated from a person’s height and weight. Here are the common guidelines:
- A BMI of 30 or higher (considered obese)
- A BMI of 27 or higher with a weight-related health problem, such as high blood pressure, type 2 diabetes, or high cholesterol
These rules are not strict for everyone, but they help doctors figure out who is most likely to benefit from tirzepatide. The goal is not only to lose weight but to improve health and reduce the risk of serious diseases.
Medical Evaluation Before Starting
Before prescribing tirzepatide, a doctor will do a careful health check. This usually includes:
- A review of the patient’s medical history
- Blood tests to check blood sugar, kidney function, and liver health
- Asking about any stomach or digestion problems
- A list of all current medications to avoid drug interactions
People who have a history of medullary thyroid cancer or a rare disease called Multiple Endocrine Neoplasia type 2 (MEN 2) should not take tirzepatide. This is because studies in animals showed a risk of thyroid tumors. Even though this risk is not confirmed in humans, doctors are careful and follow safety guidelines.
Doctor’s Role in Treatment
Tirzepatide should only be started after a full talk between the doctor and patient. Doctors explain how the medicine works, how to use it, what side effects may happen, and how often to come in for check-ups. The medicine is usually started at a low dose and increased slowly over several weeks to reduce stomach problems.
Because tirzepatide is given as a weekly shot under the skin, some people may feel unsure about using it. Nurses or doctors can teach patients how to give the shot safely at home. Some patients may also get help from a pharmacist or a caregiver.
Monitoring and Follow-Up
Once tirzepatide treatment begins, regular follow-up is important. The doctor will check:
- Weight changes over time
- Blood pressure and heart rate
- Side effects, especially related to digestion
- Lab tests to make sure organs are working well
If the medicine is not helping or if the side effects are too strong, the doctor may decide to stop treatment or try another dose. People taking tirzepatide for weight loss should also keep working on healthy eating and physical activity for the best results.
Tirzepatide may be a helpful tool for adults who are obese or overweight and have health risks linked to their weight. It is not a quick fix, and it must be prescribed by a doctor who checks that the patient is a good match. With medical guidance and regular check-ups, tirzepatide can be part of a long-term plan to improve health through weight loss.
How Quickly Does Tirzepatide Work for Weight Loss?
Tirzepatide can help people lose weight, but it does not happen overnight. The process is gradual and depends on several factors, including the dose, how the body responds to the medicine, and whether healthy habits are followed alongside the treatment. Understanding how fast weight loss happens with tirzepatide can help set realistic expectations and support better long-term results.
Early Changes in the First Few Weeks
Many people begin to see small changes in weight during the first 4 weeks of taking tirzepatide. These changes may not be large at the beginning because the medicine is started at a low dose. Starting at a low dose helps the body get used to the medicine and can lower the risk of side effects like nausea or upset stomach. During this early stage, weight loss usually ranges from 2 to 5 pounds, depending on the dose and the person’s starting weight.
This early weight loss mostly happens because tirzepatide slows down how fast the stomach empties food. This leads to a feeling of fullness that lasts longer after meals. Because of this, many people eat less without feeling very hungry. The medicine also affects parts of the brain that control hunger and cravings, which may reduce the urge to snack or eat large portions.
Progress Over 12 Weeks
Between weeks 4 and 12, the dose of tirzepatide is usually increased step-by-step to reach a full treatment level. This is known as dose titration. Each step gives the body time to adjust to the new level. As the dose increases, the effects on weight loss also grow stronger. During this period, weight loss becomes more noticeable.
In clinical studies, people lost about 10 to 15 pounds on average by the 12-week mark, depending on the dose used. Some lost even more. The weight loss was not just from water weight but included a drop in body fat, especially in the belly area. These results were seen in people with and without type 2 diabetes.
Continued Weight Loss After 6 Months
Tirzepatide continues to work beyond the first few months. By 6 months, many patients have lost 15% to 20% of their starting body weight, especially when using higher doses. For someone who weighs 250 pounds, that could mean a loss of 37 to 50 pounds. This amount of weight loss can lead to major improvements in blood pressure, cholesterol, blood sugar, and joint pain.
Most of the weight loss happens in the first 6 months, but it can continue for up to a year or longer with regular use. Some people may reach a weight plateau after several months. This is when weight loss slows down or stops for a while. Even when this happens, continuing the medication can help maintain the weight loss and prevent regaining the weight.
Role of Healthy Habits in Speeding Up Results
The speed of weight loss with tirzepatide can be improved by combining the medication with lifestyle changes. Healthy eating and regular physical activity help the body burn more calories and support better metabolism. Eating more fiber, drinking plenty of water, and avoiding high-calorie processed foods can improve the results. Exercise, such as walking, swimming, or light strength training, can also make a big difference over time.
People who take the medication without making any changes to diet or activity may still lose weight, but the results are often slower and smaller. Doctors often recommend working with a dietitian or a weight management team for the best outcome.
Individual Differences in Weight Loss Speed
Not everyone loses weight at the same pace. Age, gender, genetics, medical conditions, and medications can all play a role in how fast or how much weight is lost. Some people respond quickly to tirzepatide, while others may take longer to see changes. This does not mean the medicine isn’t working. It may simply take more time for the effects to build up.
Doctors may track weight and other health signs over time to make sure the medication is working well. If the expected weight loss is not happening after several months, the doctor may check for other issues, such as thyroid problems or hidden health conditions that affect metabolism.
Setting Realistic Expectations
It is important to understand that tirzepatide is not a quick fix. It is part of a long-term plan to treat obesity as a chronic condition. Weight loss happens over months, not days. Most experts agree that a safe and healthy rate of weight loss is about 1 to 2 pounds per week after the first month. Losing weight too quickly can cause muscle loss, tiredness, and other health problems.
Setting goals that match the natural pace of the medicine helps keep motivation strong. Small wins over time can lead to big changes in health and quality of life. With patience, support, and consistency, tirzepatide can be a powerful tool in helping people reach and keep a healthier weight.
What Are the Common Side Effects of Tirzepatide?
Tirzepatide is a medicine that helps people lose weight by acting on hormones that control appetite and digestion. While it is effective, it can also cause side effects. Most of these side effects are related to the stomach and intestines. Some are mild and go away with time, while others may need medical attention. It is important to understand what these side effects are, why they happen, and how they can be managed.
Gastrointestinal Side Effects
The most common side effects of tirzepatide affect the digestive system. These include nausea, vomiting, diarrhea, and constipation. These happen because tirzepatide slows down how quickly food leaves the stomach. This is part of how the medicine works to make a person feel full for longer, but it can also make the stomach feel uncomfortable.
- Nausea is the most frequent side effect. It may happen after the first few doses or when the dose is increased. The feeling may range from mild discomfort to strong queasiness.
- Vomiting can occur in some people, especially if the stomach is too full or irritated.
- Diarrhea means loose or watery stools and can lead to dehydration if it lasts too long.
- Constipation is less common but may happen due to slower movement of the intestines.
These side effects are usually more noticeable at the beginning of treatment or after the dose is raised. They often get better over time as the body adjusts to the medicine.
Managing Digestive Side Effects
There are several ways to reduce these stomach-related issues. Doctors usually start tirzepatide at a low dose and slowly increase it over several weeks. This slow increase helps the body get used to the medicine.
Eating smaller meals and avoiding high-fat or greasy foods can also help. Drinking plenty of water, chewing food slowly, and avoiding lying down right after eating may reduce nausea and stomach upset. For constipation, eating more fiber-rich foods and staying active can be helpful.
In some cases, a doctor may prescribe anti-nausea medicine or suggest adjusting the dose. If symptoms are severe or do not go away, medical help is needed.
Less Common Side Effects
Other less common side effects may include:
- Injection site reactions: Since tirzepatide is given as a shot under the skin, some people may have redness, swelling, or itching at the injection spot. Rotating the injection site each week (for example, switching from the stomach to the thigh) can lower the chance of skin problems.
- Fatigue or tiredness: Some people feel more tired while taking the medicine. This may be due to lower calorie intake or the body’s adjustment to new hormone levels.
- Decreased appetite: Although this is part of how the drug works, for some people the appetite loss may feel too strong.
These side effects are usually not dangerous but can be bothersome. They tend to improve over time or with small changes in how the medicine is used.
Rare but Serious Side Effects
Tirzepatide, like other medicines that act on GLP-1 receptors, may also carry risks of serious side effects. These are uncommon but important to know about.
- Pancreatitis: This is inflammation of the pancreas, a gland that helps with digestion. Signs include severe stomach pain that may reach the back, nausea, and vomiting. This condition needs emergency care.
- Gallbladder problems: Some people have developed gallstones or inflammation of the gallbladder while on tirzepatide. Symptoms may include pain in the upper right side of the stomach, fever, or yellowing of the skin and eyes (jaundice).
- Low blood sugar (hypoglycemia): This mainly happens in people with type 2 diabetes who also take insulin or other diabetes medicines. Symptoms include sweating, dizziness, shaking, or feeling confused.
Doctors check for these risks before starting tirzepatide and may do blood tests during treatment to monitor safety. Patients are also advised to report any unusual or severe symptoms right away.
Tirzepatide can cause side effects, especially related to digestion. Nausea, vomiting, diarrhea, and constipation are the most common. These are usually mild and get better with time. Less common side effects include tiredness and injection site reactions. Serious problems like pancreatitis or gallbladder disease are rare but can occur. Most side effects can be managed with careful monitoring, lifestyle changes, and working closely with a doctor. Understanding what to expect can help people use this medication safely and effectively.
Is Tirzepatide Safe for Long-Term Use?
Tirzepatide is a medication that many people are now using to help with weight loss. It is still a fairly new drug, so it is important to understand how safe it is, especially when used over a long period of time. Researchers and doctors are continuing to study tirzepatide to see what happens when people use it for many months or even years. So far, the data looks promising, but there are some important things to keep in mind.
Clinical Trial Safety Data
Tirzepatide has been tested in large clinical trials, including studies called the SURPASS and SURMOUNT trials. These trials followed people for up to 72 weeks, or about 1.5 years. During this time, researchers looked closely at side effects and other safety issues.
Most people in the studies tolerated tirzepatide well. The most common side effects were mild to moderate and happened mostly in the first few weeks. As the body adjusts to the medication, these side effects often become less bothersome or go away.
Even though the studies were fairly long, they still do not show what might happen if someone takes tirzepatide for five years or more. That kind of information takes longer to collect, so scientists are still watching people who take the drug. This kind of long-term monitoring is called post-marketing surveillance, and it helps doctors learn more about how the drug works over time.
Chronic Use in Obesity Management
Obesity is a long-term health condition. People who are overweight or obese often need treatment that lasts many months or years. Because of this, any medication used for weight loss must be safe to take long-term.
Tirzepatide was first approved to treat type 2 diabetes, and many people with diabetes take medications like this for many years. So far, the results have shown that tirzepatide can be used safely over extended periods for blood sugar control. This gives doctors hope that it may also be safe when used for obesity.
However, weight loss medications are often used by people who do not have diabetes. More research is being done to confirm that tirzepatide is also safe for non-diabetic individuals using it only for weight loss.
Monitoring and Safety Checks
Anyone who takes tirzepatide for a long time needs regular check-ups. Doctors will usually check for common side effects and make sure that the drug is working as expected. Some people may need blood tests to check how their liver and pancreas are doing. This is important because, although rare, there are some concerns about possible inflammation of the pancreas, known as pancreatitis.
Doctors also watch for signs of gallbladder problems, such as pain in the upper right side of the belly, nausea, or yellowing of the skin. This is because losing weight quickly, or using certain weight loss medications, can increase the risk of gallstones or gallbladder disease.
People with a history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not use tirzepatide. Animal studies showed a possible risk of thyroid tumors, and although this has not been proven in humans, the warning remains as a safety measure.
Research on Heart and Metabolic Health
Another important part of long-term safety is how tirzepatide affects the heart and blood vessels. Obesity increases the risk of heart disease, high blood pressure, and stroke. So far, the studies have not shown any major problems with tirzepatide and heart health. In fact, many people in the clinical trials saw improvements in their blood pressure, cholesterol, and blood sugar levels.
Researchers are now doing even longer studies to learn more. One major study is looking at whether tirzepatide can lower the risk of heart attacks and strokes in people with obesity. These results will help doctors decide how tirzepatide fits into long-term care for patients.
Regulatory Oversight and Future Safety Reviews
Since tirzepatide is still relatively new, it is closely watched by government health agencies like the U.S. Food and Drug Administration (FDA). These agencies require companies to report any new side effects or safety concerns that show up after the drug is on the market. This process helps keep the public safe and ensures that patients and doctors receive up-to-date information.
Doctors are also encouraged to report any unexpected issues they see in their patients. These reports can lead to updates on drug labels or further research if needed.
Tirzepatide appears to be safe for long-term use based on current data from clinical trials. Most side effects are mild and go away over time. People who take the drug for many months or more should have regular check-ups and monitoring. While serious side effects are rare, doctors stay alert for pancreatitis, gallbladder disease, and possible thyroid concerns.
Because obesity is a chronic condition, the safety of any long-term medication is very important. Ongoing studies and safety monitoring will continue to give more information about tirzepatide’s long-term use. For now, early data suggests that it may offer a safe and effective option for many people who struggle with obesity.
How Tirzepatide Is Given and What Monitoring Is Needed
Tirzepatide is given as a weekly injection under the skin, also called a subcutaneous injection. It is not a pill or a medicine that is taken by mouth. This injection goes under the skin of the stomach, thigh, or upper arm. Most people give the shot to themselves after learning how to do it safely. A doctor, nurse, or pharmacist usually teaches this process at the beginning.
Tirzepatide comes in a pre-filled injection pen. This pen is designed to be easy to use. It contains the right amount of medicine for each dose. The needle is small, and the shot usually causes only a little pain. The injection should be given on the same day each week, but the exact time of day does not matter. If needed, the day of the week can be changed, as long as the next dose is given at least 72 hours after the last one.
Starting and Raising the Dose
The dose of tirzepatide is started low and increased slowly over time. This is done to help the body get used to the medicine and reduce the chance of side effects, especially nausea or stomach upset.
Here is a common dosing schedule:
- Week 1 to 4: 2.5 mg once weekly
- Week 5 to 8: 5 mg once weekly
- Week 9 and beyond: The doctor may increase the dose to 7.5 mg, 10 mg, 12.5 mg, or even 15 mg once a week, depending on how well the medicine is working and how well it is tolerated.
Not everyone needs the highest dose. Some people do very well on 5 mg or 10 mg per week. Doctors choose the best dose based on how much weight is lost, blood sugar changes (in people with diabetes), and whether any side effects occur.
How to Store Tirzepatide
Tirzepatide must be stored in the refrigerator before use. Once removed, it can stay at room temperature for up to 21 days, but it should not be kept in direct sunlight or in very hot places. The pen should never be frozen. Used pens are thrown away and not reused.
What to Watch for While Using Tirzepatide
Doctors usually check several things while someone is taking tirzepatide. Even though it helps with weight loss, the medicine can have side effects or cause changes in the body that need to be followed closely.
Here are common things that need to be monitored:
- Body weight – Regular tracking of weight helps show how well the medicine is working. Some people may lose weight quickly in the first few months, while others may lose weight more slowly.
- Blood sugar levels – For people with type 2 diabetes, blood sugar checks are important. Tirzepatide lowers blood sugar, and if other diabetes medicines are being used, blood sugar could become too low (called hypoglycemia). Doctors may lower other medicines to avoid this.
- Stomach symptoms – Nausea, vomiting, or diarrhea are the most common side effects. If these symptoms are strong or last a long time, the dose may need to be lowered or the increase in dose may be delayed.
- Lab tests – Blood tests may be done to check the pancreas, liver, and kidney function. This is not always needed for everyone, but may be done if there is a concern or if the person has other health problems.
- Injection site reactions – Redness or pain at the injection site can happen but is usually mild. Changing the injection spot each week helps prevent this.
Keeping Up With Follow-Up Visits
Doctors will usually schedule follow-up visits every few months. At these visits, weight is checked, side effects are discussed, and the dose of tirzepatide may be adjusted. If a person is doing well and not having problems, they may only need to check in a few times a year after the dose is stable.
Patients taking tirzepatide as part of a weight management plan often also see a dietitian, exercise coach, or weight loss team. These visits help make sure that the medicine is used along with healthy eating and physical activity. When combined, the results can be stronger and longer-lasting.
Importance of Routine and Safety
Taking tirzepatide on the same day each week and following instructions carefully helps get the best results. Missing doses can lower how well the medicine works. If a dose is missed, it should be taken as soon as remembered, as long as it is within 4 days (96 hours) of the missed dose. If more than 4 days have passed, the missed dose should be skipped and the next one taken on the usual day.
Tirzepatide should never be taken more than once in a 3-day period to “make up” for a missed dose. Doing so could cause serious side effects.
Staying in touch with the healthcare team and reporting any unusual symptoms early is the best way to stay safe while using tirzepatide. This medicine has helped many people lose weight and improve health, but it must be used correctly and with care.
How Does Tirzepatide Differ from GLP-1 Agonists Like Semaglutide?
Tirzepatide and semaglutide are both injectable medicines that help people lose weight. While they work in similar ways, there are also important differences. These differences affect how the body responds, how much weight people can lose, and how well the medicines are tolerated. Understanding these differences can help explain why tirzepatide is gaining attention in the treatment of obesity.
What Are GLP-1 Agonists?
Semaglutide is a GLP-1 receptor agonist. This means it copies the action of a natural hormone in the body called glucagon-like peptide-1 (GLP-1). This hormone is released after eating and helps control blood sugar. It also slows down how quickly the stomach empties food and helps the brain feel full.
By mimicking this hormone, semaglutide helps lower blood sugar in people with type 2 diabetes. It also reduces appetite, which leads to lower food intake and weight loss. Semaglutide is available in both daily and weekly forms, but for weight loss, the weekly version (brand name Wegovy) is most commonly used.
What Makes Tirzepatide Different?
Tirzepatide is a newer medicine that acts on two hormone pathways, not just one. It is called a dual GIP and GLP-1 receptor agonist. This means it mimics two hormones: glucose-dependent insulinotropic polypeptide (GIP) and GLP-1.
Like GLP-1, GIP also helps regulate insulin and plays a role in metabolism. On its own, GIP does not have a strong effect on weight. But when it is combined with GLP-1 in a single medication like tirzepatide, the effects seem to be stronger than with GLP-1 alone. Scientists believe that this dual action may lead to better control of blood sugar and greater weight loss.
Stronger Weight Loss Effects
Clinical trials have shown that tirzepatide can lead to more weight loss than semaglutide. In head-to-head studies, people taking tirzepatide lost more weight than those taking the highest dose of semaglutide. For example, some people on the highest dose of tirzepatide (15 mg once weekly) lost more than 20% of their body weight. This is close to the amount of weight loss seen with bariatric surgery.
Semaglutide also leads to meaningful weight loss, especially at doses used for obesity (like 2.4 mg per week). However, the results with tirzepatide suggest that it may be even more effective, possibly because of the added GIP effect.
Differences in How the Body Responds
Tirzepatide and semaglutide both slow down the emptying of the stomach, which helps people feel full for longer. They also reduce appetite and help lower food intake. But tirzepatide may work in a slightly different way.
The GIP part of tirzepatide appears to make the body more sensitive to insulin and may reduce fat buildup in the liver. It might also help balance the GLP-1 side effects, especially stomach problems like nausea. This could make tirzepatide easier for some people to tolerate.
Side Effects and Tolerability
Both medications can cause side effects, especially when people first start taking them. The most common side effects are related to the stomach, such as nausea, vomiting, diarrhea, and constipation. These symptoms usually happen during dose increases and may go away over time.
Some studies suggest that tirzepatide might have a slightly better tolerability profile compared to semaglutide. This could be because of the way GIP works in the body. However, both medicines need careful dose adjustments to reduce side effects.
Neither medicine is linked to addiction or withdrawal. They do not act on the brain’s reward system but instead work through natural hormone pathways.
Dosing and Administration
Both tirzepatide and semaglutide are given as weekly injections under the skin. They are available in prefilled pens, and most people can learn to inject them at home after training.
Tirzepatide has multiple dose levels: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Semaglutide used for weight loss is available at doses up to 2.4 mg per week. Both medications start at lower doses and increase slowly to help the body adjust and reduce the chance of side effects.
Why These Differences Matter
The dual action of tirzepatide sets it apart from older weight-loss medicines. By targeting two hormones instead of one, it seems to offer more powerful effects on weight and blood sugar. This may lead to better results for people living with obesity, especially those who have tried other treatments without success.
While semaglutide has been a major step forward in obesity care, tirzepatide may represent the next phase in treatment. Ongoing studies are looking at how it affects long-term health, including heart disease and metabolic risk.
Choosing between tirzepatide and semaglutide depends on many factors, including medical history, cost, insurance coverage, and personal response to treatment. But the added GIP pathway in tirzepatide could make a real difference in how the body handles fat, appetite, and insulin — offering new hope for people struggling with obesity.
How Much Does Tirzepatide Cost and Is It Covered by Insurance?
Tirzepatide is a medicine that must be prescribed by a doctor. It is sold under the brand name Mounjaro for people with type 2 diabetes. The price of tirzepatide can be high. In the United States, the cost is usually between $970 and $1,100 per month, depending on the dose. This price is for a box that contains four weekly injections.
The cost may be a little different based on the pharmacy or where the person lives. Even with health insurance, many people still pay part of the cost. Without insurance, the full price can be very hard to afford.
Insurance Coverage for Diabetes
Tirzepatide is approved by the U.S. Food and Drug Administration (FDA) to treat type 2 diabetes. For people with diabetes, health insurance is more likely to help cover the cost. Most insurance companies, including Medicare and Medicaid, will help pay for the medicine when it is used to control blood sugar.
When insurance covers tirzepatide, the person may only need to pay a copay, which is usually much lower than the full price. The exact amount depends on the type of plan and whether the drug is on the plan’s list of covered medications, called a formulary.
Off-Label Use for Weight Loss
Even though tirzepatide helps people lose weight, it is not yet approved by the FDA for weight loss alone. Many doctors still prescribe it off-label to treat obesity, especially when the person also has conditions like high blood pressure, sleep apnea, or prediabetes.
When tirzepatide is used off-label for obesity, insurance companies often do not cover it. Many health plans still see weight loss drugs as optional and not necessary, even though obesity is a medical condition. This makes it harder for people who need the medicine for weight loss to get it covered.
Ways to Save on Tirzepatide
The company that makes tirzepatide, Eli Lilly, offers a savings card for people with private insurance. This card can help lower the cost to as little as $25 per month, but it is only available to people who meet certain rules. People on government insurance like Medicare or Medicaid usually cannot use these savings cards.
Some people also try telehealth programs or online clinics that offer weight loss services. These programs may include doctor visits, lab tests, and the medicine for one monthly fee. The cost can be lower than buying the drug at full price, but these programs are not always covered by insurance either.
Is Tirzepatide Cost-Effective?
Some experts believe that tirzepatide could help save money in the long term by preventing serious health problems. Losing weight can reduce the risk of heart disease, stroke, type 2 diabetes, and more. People who lose weight may also need fewer other medications or doctor visits.
If tirzepatide helps prevent these problems, it may save both patients and the health system money over time. Because of this, some insurance companies are beginning to rethink their policies about weight loss drugs.
Health Equity and Access
There are concerns that tirzepatide is not equally available to everyone. People who live in lower-income areas or who do not have good insurance may not be able to get the drug. This creates a gap between those who can afford the treatment and those who cannot.
Public health leaders are calling for better access to obesity care for all patients. They believe that more people should be able to get medications like tirzepatide, no matter their income or insurance status.
Right now, the cost of tirzepatide and lack of insurance coverage make it hard for many people to use it for weight loss. As more research shows how effective it is, and as the FDA considers approval for obesity treatment, insurance rules may start to change.
Better policies, expanded coverage, and more savings programs could help more people benefit from this medicine in the future. Making tirzepatide more affordable could be a big step forward in fighting obesity.
Could Tirzepatide Change the Future of Obesity Treatment?
Obesity has long been viewed as a problem caused by poor habits, like eating too much or not moving enough. But new science shows it is much more complex. Many factors play a role, including hormones, brain signals, genetics, and metabolism. These factors affect how hungry people feel, how their bodies store fat, and how much energy they burn.
Tirzepatide works by targeting some of these deeper causes. It helps control hunger and fullness by acting on natural hormones. Because of this, it is not just helping people lose weight—it is also changing how doctors understand and treat obesity.
How Tirzepatide Works Differently
Most older weight-loss drugs target just one hormone or one part of the brain. Tirzepatide is different. It targets two hormones: GLP-1 and GIP. These hormones help the body regulate appetite, insulin, and how food moves through the stomach.
By using both hormone pathways, tirzepatide gives a stronger and longer-lasting signal to the brain. People who take it tend to feel full sooner and eat less. It also helps the body use insulin better and lowers blood sugar levels. These combined actions make it more powerful than many past medications.
Moving from Lifestyle to Medical Treatment
For many years, weight loss treatment focused mainly on diet and exercise. While these remain important, they are not always enough. Many people lose weight at first, but gain it back over time. This happens because the body has systems that fight weight loss. For example, after losing weight, hunger hormones may increase and metabolism may slow down.
Tirzepatide helps fight against these effects. By changing how the body and brain react to food, it makes it easier to keep weight off. Because of this, more doctors are starting to treat obesity like they treat other long-term diseases—with the help of medicine, not just lifestyle changes.
Impact on Medical Guidelines
Medical groups are beginning to update their guidelines to include medications like tirzepatide. Some now recommend medicine for people with a high body mass index (BMI) and related health problems. The goal is to treat obesity early and prevent complications like diabetes, heart disease, and high blood pressure.
Tirzepatide offers new hope for people who have tried other methods without success. It may be especially helpful for those who need to lose a large amount of weight, but are not able to have surgery.
Changing Public Understanding and Reducing Stigma
When people hear that obesity is partly caused by hormones and brain signals, they may be less likely to blame themselves or others. Tirzepatide is helping spread this message. Understanding that obesity is a disease—not a choice—can reduce shame and encourage more people to seek help.
This change in how society talks about obesity may also improve how people are treated by their doctors, employers, and even their families.
Beyond Weight Loss: Future Medical Uses
Researchers are studying tirzepatide for other health problems that are linked to obesity. These include:
- Heart disease
- Fatty liver disease (also called NAFLD or NASH)
- Sleep apnea
- Polycystic ovary syndrome (PCOS)
If it helps in these areas, tirzepatide may become part of treatment for many different conditions—not just weight loss.
There is also interest in whether it can reduce the risk of heart attacks and strokes. Some early results are promising, but more research is needed.
Expanding Access and Treatment Programs
As more people benefit from tirzepatide, there may be changes in how doctors offer care. Obesity treatment could include:
- Medication like tirzepatide
- Nutrition coaching
- Fitness support
- Counseling or therapy
Doctors might work in teams to help patients lose weight and stay healthy over the long term.
Insurance companies may also begin to cover this kind of care more often, especially if it leads to fewer health problems and lower medical costs.
A Shift Toward Long-Term Management
Tirzepatide is showing that long-term weight loss is possible with the right tools. Like high blood pressure or asthma, obesity may need treatment over many years. Tirzepatide could become part of a long-term care plan to help people maintain a healthy weight and avoid serious illnesses.
Even though it is still new, tirzepatide is already changing how obesity is treated and understood. If future studies continue to show strong results, it may become a key part of obesity care around the world.
Conclusion: A Paradigm Shift in Weight Management
Tirzepatide is helping doctors and researchers think differently about how to treat obesity. For many years, the main advice for losing weight was to eat less and exercise more. While this advice is still important, it does not work well for everyone. Obesity is a complex disease. It involves hormones, the brain, the gut, and even genetics. Many people struggle with weight loss, even when they follow healthy habits. Tirzepatide is showing that a new approach is possible—one that works with the body’s own systems to help control hunger and manage weight over time.
Tirzepatide is a medication that targets two important hormones in the body: GLP-1 and GIP. These hormones help control blood sugar and appetite. Tirzepatide copies the effects of both hormones. It helps people feel full faster and stay full longer. It also reduces how much food people want to eat. These effects lead to steady weight loss over time. In clinical trials, people lost a large amount of weight—more than 20% of their body weight in some cases. This is a level of weight loss that used to be possible only with surgery.
The results from major studies, such as the SURMOUNT and SURPASS trials, show that tirzepatide works well for both people with type 2 diabetes and those without diabetes. These studies also found that the medication is safe when used for over a year. Many people taking tirzepatide saw improvements not only in their weight but also in their blood sugar, blood pressure, and cholesterol levels. These changes reduce the risk of heart disease, stroke, and other serious health problems.
Even though tirzepatide has side effects, most of them are mild. The most common ones are nausea, diarrhea, and constipation. These side effects often happen when starting the medication or when increasing the dose. Doctors usually start with a low dose and raise it slowly to help avoid these problems. Serious side effects, like pancreatitis or gallbladder problems, are rare. Most people can take tirzepatide safely, especially when their doctor checks their health regularly.
The way tirzepatide is given also helps with long-term use. It is injected only once a week, which is easier than taking pills every day. People can learn to give themselves the shots at home. This makes it more convenient and helps people stick with the treatment. Doctors also check weight, blood sugar, and side effects regularly to make sure the medication is working well.
Tirzepatide is changing the way health experts think about treating obesity. In the past, many people believed that obesity was just a problem of willpower. Now, more doctors understand that it is a real disease that needs medical treatment, just like diabetes or high blood pressure. Tirzepatide helps prove that treating obesity with medicine can work. It shows that the brain and gut play a major role in weight gain, and that these systems can be targeted with the right medication.
Cost is still a challenge. Tirzepatide can be expensive, and not all insurance plans cover it for weight loss. Some people can get help through patient programs, but not everyone qualifies. As more studies are done and the medication becomes more widely used, there may be changes in how insurance companies handle coverage. Health systems and governments may also need to decide how to support access to this type of treatment.
Tirzepatide may soon lead to new guidelines for treating obesity. It could be used earlier in treatment, not just after lifestyle changes fail. Researchers are also studying whether tirzepatide can help prevent other diseases linked to obesity, such as heart disease or sleep apnea. In the future, more people may be able to take this medicine to stay healthy and live longer lives.
The growing success of tirzepatide points to a future where obesity is treated as a medical condition, not just a personal struggle. This medication is more than a new drug—it is a sign of a major change in how doctors, researchers, and patients approach weight loss. With more research and better access, tirzepatide may help millions of people take control of their health and reduce the risks linked to obesity.
Research Citations
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., … Jastreboff, A. M. (2022). Once‐weekly tirzepatide versus placebo for weight management in adults without diabetes (SURMOUNT-1): A randomised, controlled, double-blind, phase 3 trial. New England Journal of Medicine, 387(3), 205–216.
Frias, J. P., Bastyr, E., Vignati, L., Cui, X., Lu, K., Haluzík, M., … Rosenstock, J. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): A randomised, open-label, phase 3 trial. The Lancet, 398(10300), 143–155.
Rosenstock, J., Wysham, C., Frías, J. P., Charpentier, G., Trautmann, M. E., Pieber, T. R., … Cariou, B. (2021). Efficacy and safety of tirzepatide in patients with type 2 diabetes: A randomised, double-blind, placebo-controlled, phase 3 trial (SURPASS-5). Diabetes Care, 44(8), 1806–1814.
Rosenstock, J., Perkins, B. A., Huyck, S., Breiter, S., Marx, N., Andersen, K., … Frias, J. P. (2022). Efficacy and safety of tirzepatide versus insulin degludec in patients with type 2 diabetes (SURPASS-3): A randomised, open-label, phase 3 trial. Diabetes, Obesity and Metabolism, 24(8), 1886–1894.
Jastreboff, A. M., Arnold, M., Samuels, J., Jensen, D., Tran, A., Shi, T., … Davies, M. (2023). Tirzepatide after intensive lifestyle intervention in adults with obesity: A phase 3, double-blind, placebo-controlled trial. Nature Medicine, 29(8), 1528–1538.
Coskun, T., Sloop, K. W., Loghin, C., Alsina-Fernandez, J., Urva, S., Bokvist, K. B., … Wu, Y. (2020). LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes, with sustained glycaemic control and weight loss: A randomised, placebo-controlled and active comparator-controlled phase 2 trial. The Lancet, 396(10267), 489–501.
Frias, J. P., Bastyr, E. J., Vargas, L. L., Vignati, L., Cui, X., Lu, K., … Haluzík, M. (2021). Tirzepatide once weekly versus semaglutide in patients with type 2 diabetes: SURPASS-2 trial results and weight-loss analysis. Journal of Clinical Endocrinology & Metabolism, 106(5), 1314–1325.
Jastreboff, A. M., Frías, J. P., Han, J., Trautmann, M., Marso, S. P., Goodrich, T. A., … Frias, J. P. (2024). Clinical efficacy and safety of tirzepatide for obesity management: A systematic review and meta-analysis. Frontiers in Public Health, 12, 1277113.
Zhong, M., Zhou, J., Peng, B., Xu, H., & He, X. (2024). Gastrointestinal tolerability and weight reduction associated with tirzepatide in patients with obesity: Results from the SURMOUNT trials. Diabetes, Obesity and Metabolism, 26(2), 375–386.
Wedland, C. H., Willemen, H. L., Lee, Y., Zhang, M., Finan, B., DiMarchi, R. D., & Campbell, J. E. (2020). Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight, 5(17), e134191.
Questions and Answers: How Tirzepatide Reduce Weight
Tirzepatide is a medication that mimics two hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)—to help regulate blood sugar and reduce appetite.
Tirzepatide reduces weight by decreasing appetite, slowing gastric emptying, and improving insulin sensitivity, leading to reduced calorie intake and increased fat loss.
Tirzepatide activates brain receptors that help control hunger, leading to reduced appetite and calorie intake.
Slowing gastric emptying means food stays in the stomach longer, which promotes a feeling of fullness and reduces the urge to eat.
Yes, tirzepatide enhances insulin secretion in response to meals and lowers blood sugar levels, which helps prevent fat storage and supports weight loss.
Unlike many other drugs, tirzepatide targets both GLP-1 and GIP receptors, offering potentially greater weight loss than GLP-1-only drugs like semaglutide.
In clinical trials, people using tirzepatide have lost an average of 15–22% of their body weight over 72 weeks, depending on the dose.
Tirzepatide is approved for adults with type 2 diabetes and is also being studied and used off-label for obesity and overweight without diabetes.
Yes, tirzepatide works best when combined with a healthy diet and regular physical activity.
Yes, discontinuing tirzepatide may lead to weight regain, especially without continued lifestyle modifications.
Dr. Kevin Kargman
Dr. Kevin J. Kargman is a pediatrician in Sewell, New Jersey and is affiliated with multiple hospitals in the area, including Cooper University Health Care-Camden and Jefferson Health-Stratford, Cherry Hill and Washington Township. (Learn More)